On the other hand, pharmacological inhibition of LonP1 using CDDO-Me was found to transcriptionally upregulate almost all genes involved in the mitochondrial and the cytoplasmic stress response pathways described above in both cancer cell lines. This evidence concerns the gene LONP1 and cancer.